📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Frailty, multimorbidity and polypharmacy: exploratory analyses of the effects of empagliflozin from the EMPA-KIDNEY trial. (2024)

First Author: Mayne KJ

Attributed to: Adiposity and kidney disease: observations from large blood-based prospective cohorts across a wide range of different populations funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.2215/cjn.0000000000000498

PubMed Identifier: 38949880

Publication URI: http://europepmc.org/abstract/MED/38949880

Type: Journal Article/Review

Volume: 19

Parent Publication: Clinical journal of the American Society of Nephrology : CJASN

Issue: 9

ISSN: 1555-9041